Report cover image

EMEA Point-Of-Care Diagnostics Market Growth, Size, Trends Analysis - By Product, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jul 08, 2025
Length 161 Pages
SKU # SPER20314909

Description

EMEA Point-Of-Care Diagnostics Market Introduction and Overview

According to SPER market research, ‘EMEA Point-Of-Care Diagnostics Market Size- By Product, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the EMEA Point-Of-Care Diagnostics Market is predicted to reach 25.81 billion by 2034 with a CAGR of 6.43%.

A diagnostic kit is a collection of equipment and reagents designed to detect, analyse, or monitor certain health problems, infections, or diseases in patients. These diagnostics provide quick responses and allow doctors to make timely decisions without the need for centralised laboratory equipment. PoC diagnostics have a wide range of applications, including glucose monitoring, infectious disease detection, cardiac indicators, and pregnancy testing.

Restraints:The EMEA point-of-care diagnostics market has several obstacles that prevent it from realising its full potential. A fragmented regulatory environment across countries increases approval time and complicates compliance. The high initial prices of current PoC devices impede adoption, particularly in resource-constrained environments. Data privacy concerns, particularly under legislation like GDPR, pose hurdles for linked and digital testing systems.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By End User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Abbott, BD (Becton Dickinson), BIOMÉRIEUX, Danaher Corporation, F. Hoffmann-La Roche Ltd, Nova Biomedical, QIAGEN, Siemens Healthcare Private Limited, Trividia Health, Inc, Werfen.

EMEA Point-Of-Care Diagnostics Market Segmentation:

By Product: Based on the product, EMEA Point-Of-Care Diagnostics Market is segmented as; Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Vikram, Cardiac Markers, Thyroid Stimulating Hormone, Haematology, Primary Care Systems.

By End User:
Based on the End User, EMEA Point-Of-Care Diagnostics Market is segmented as; Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory, Others.

By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

161 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. EMEA Point-Of-Care Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in EMEA Point-Of-Care Diagnostics Market
7. EMEA Point-Of-Care Diagnostics Market by Product (USD Million) 2021-2034
7.1. Glucose Testing
7.2. Hb1Ac Testing
7.3. Coagulation Testing
7.4. Fertility/Pregnancy
7.5. Vikram
7.6. Cardiac Markers
7.7. Thyroid Stimulating Hormone
7.8. Haematology
7.9. Primary Care Systems
8. EMEA Point-Of-Care Diagnostics Market by End UseR (USD Million) 2021-2034
8.1. Hospitals
8.2. Home
8.3. Assisted Living Healthcare Facilities
8.4. Laboratory
8.5. Others
9. EMEA Point-Of-Care Diagnostics Market (USD Million) 2021-2034
9.1. EMEA Point-Of-Care Diagnostics Market Size and Market Share
10. EMEA Point-Of-Care Diagnostics Market by Region, (USD Million) 2021-2034
10.1. Europe
10.1.1. UK
10.1.2. Germany
10.1.3. France
10.1.4. Italy
10.1.5. Spain
10.1.6. Denmark
10.1.7. Sweden
10.1.8. Norway
10.2. Middle East and Africa
10.2.1. South Africa
10.2.2. UAE
10.2.3. Saudi Arabia
10.2.4. Kuwait
11. Company Profile
11.1. Abbott
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. BD (Becton Dickinson)
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. BIOMÉRIEUX
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Danaher Corporation
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. F. Hoffmann-La Roche Ltd
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Nova Biomedical
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. QIAGEN
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Siemens Healthcare Private Limited
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Trividia Health, Inc
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Werfen
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.